Peninsula biotech hikes IPO price targets by 28%

There are now three Bay Area biotechs likely to go public in June, as many as have done IPOs in the first five months of the year.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.